• Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies 

      Jimenez Balarezo, Moraima; Roldan Galvan, Elisa; Fernandez Naval, Candela; Medina-Gil, Daniel; Peralta Garzon, Soraya; Pujadas, Gemma; Hernández Buñuel, Cristina; Pagès Geli, Carlota; Gironella Mesa, Mercedes; Orti Pascual, Guillem; Barba Suñol, Pere; Pumarola Suñé, Tomàs; Cabirta Touzon, Alba; Catalá, Eva; Valentin, Mercedes; Orfao, Alberto; González, Marcos; Ruiz Camps, Isabel; Valcarcel Ferreiras, David; Bosch Albareda, Francesc; Hernández González, Manuel; Crespo Maull, Marta; Esperalba Esquerra, Juliana; Villacampa Javierre, Guillermo; Marin Niebla, Ana; Martínez Gallo, Mónica; Fox, Maria Laura; Abrisqueta, Pau; Campins Martí, Magda (American Society of Hematology, 2022-02-08)
    • Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study 

      García-Pérez, Javier; González Pérez, Maria; Castillo de la Osa, María; Borobia, Alberto M.; Bertrán, María Jesús; Fuentes Camps, Inmaculada; Agustí Escasany, Maria Antònia; Campins Martí, Magda; Castaño, Luis (Elsevier, 2022-08)
    • Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab 

      Carbonell Mirabent, Pere; Rodríguez Barranco, Marta; Castillo Justribo, Joaquin; Guío-Sánchez, Claudia; Carvajal, René; Zabalza, Ana; Martínez-Gómez, Xavier; Esperalba, Juliana; Pappolla, Agustin; Rando Segura, Ariadna; Cobo-Calvo, Alvaro; TUR, CARMEN; Rio, Jordi; Comabella Lopez, Manuel; Rodrigo Pendás, José Ángel; Braga da Silva Rezende, Nathane; Mongay-Ochoa, Neus; Vidal-Jordana, Angela; Arrambide, Georgina; Rodriguez Acevedo, Breogan; midaglia, luciana; BORRAS BERMEJO, BLANCA; Galan, Ingrid; Sastre Garriga, Jaume; Montalban, Xavier; Otero-Romero, Susana; Tintore, Mar (American Medical Association, 2024-04-01)